GLOBUS MEDICAL INC (GMED)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 1.5B 3B 4.5B Q3 '21: 941.5M Q4 '21: 958.1M Q1 '22: 961.3M Q2 '22: 973.9M Q3 '22: 998.4M Q4 '22: 1B Q1 '23: 1.1B Q2 '23: 1.1B Q3 '23: 1.2B Q4 '23: 1.6B Q1 '24: 1.9B Q2 '24: 2.2B Q3 '24: 2.5B Q4 '24: 2.5B Q1 '25: 2.5B Q2 '25: 2.6B Q3 '25: 2.8B Q4 '25: 2.9B Q1 '26: 3.1B Q2 '26: 3.1B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 500M 1B 1.5B Q3 '19: 592.5M Q4 '19: 605.4M Q1 '20: 606M Q2 '20: 553.7M Q3 '20: 561.9M Q4 '20: 571.6M Q1 '21: 602.2M Q2 '21: 691.1M Q3 '21: 703.2M Q4 '21: 718.9M Q1 '22: 717.9M Q2 '22: 726M Q3 '22: 743.4M Q4 '22: 759.1M Q1 '23: 793.6M Q2 '23: 813.6M Q3 '23: 873.2M Q4 '23: 1B Q1 '24: 1.2B Q2 '24: 1.3B Q4 '19 Q3 '20 Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24

Operating Income TTM

0 250M 500M 750M Q3 '21: 212.3M Q4 '21: 172M Q1 '22: 163.8M Q2 '22: 185.8M Q3 '22: 192.1M Q4 '22: 228M Q1 '23: 237.9M Q2 '23: 236.3M Q3 '23: 177M Q4 '23: 133.1M Q1 '24: 84.7M Q2 '24: 68.1M Q3 '24: 115.8M Q4 '24: 166M Q1 '25: 255M Q2 '25: 281.5M Q3 '25: 370.8M Q4 '25: 479.8M Q1 '26: 533.2M Q2 '26: 639.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

0 200M 400M 600M Q3 '21: 187M Q4 '21: 149.2M Q1 '22: 141.9M Q2 '22: 155M Q3 '22: 155.2M Q4 '22: 190.2M Q1 '23: 201.2M Q2 '23: 204.3M Q3 '23: 157.9M Q4 '23: 122.9M Q1 '24: 66.6M Q2 '24: 40.7M Q3 '24: 91.5M Q4 '24: 103M Q1 '25: 185.6M Q2 '25: 356.6M Q3 '25: 423.8M Q4 '25: 537.9M Q1 '26: 586.7M Q2 '26: 535.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 400M 800M 1.2B Q3 '21: 238.3M Q4 '21: 239.2M Q1 '22: 243.4M Q2 '22: 248M Q3 '22: 254.9M Q4 '22: 263.7M Q1 '23: 275.4M Q2 '23: 283.4M Q3 '23: 353.3M Q4 '23: 548.2M Q1 '24: 718.8M Q2 '24: 902.4M Q3 '24: 1B Q4 '24: 1B Q1 '25: 989.4M Q2 '25: 978.1M Q3 '25: 960.1M Q4 '25: 957.8M Q1 '26: 996.5M Q2 '26: 989.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

0 350M 700M 1.1B Q3 '21: 280.2M Q4 '21: 276.3M Q1 '22: 257.4M Q2 '22: 235.1M Q3 '22: 190.7M Q4 '22: 178.5M Q1 '23: 187.1M Q2 '23: 185.2M Q3 '23: 202.8M Q4 '23: 243.5M Q1 '24: 242.6M Q2 '24: 261.8M Q3 '24: 415M Q4 '24: 520.6M Q1 '25: 645.6M Q2 '25: 669.2M Q3 '25: 715.2M Q4 '25: 753.4M Q1 '26: 778.5M Q2 '26: 910.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

0 300M 600M 900M Q3 '21: 226.3M Q4 '21: 219.4M Q1 '22: 194.2M Q2 '22: 156.5M Q3 '22: 118M Q4 '22: 104.4M Q1 '23: 117M Q2 '23: 121.1M Q3 '23: 129.1M Q4 '23: 165.2M Q1 '24: 151.7M Q2 '24: 161M Q3 '24: 293.8M Q4 '24: 405.2M Q1 '25: 522.6M Q2 '25: 527.4M Q3 '25: 579.6M Q4 '25: 588.8M Q1 '26: 610.3M Q2 '26: 755.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 50M 100M 150M Q1 '20: 102.1M Q2 '20: 97.5M Q3 '20: 100.5M Q1 '21: 102.4M Q2 '21: 103.5M Q3 '21: 104.4M Q1 '22: 104.1M Q2 '22: 102.9M Q3 '22: 101.4M Q1 '23: 102.2M Q2 '23: 101.8M Q3 '23: 115.2M Q1 '24: 135.4M Q2 '24: 137M Q3 '24: 138.1M Q1 '25: 139.8M Q2 '25: 136.5M Q3 '25: 135.4M Q1 '26: 138.2M Q2 '26: 137.4M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 1.50 3.00 4.50 Q3 '21: 1.81 Q4 '21: 1.43 Q1 '22: 1.36 Q2 '22: 1.49 Q3 '22: 1.51 Q4 '22: 1.86 Q1 '23: 1.97 Q2 '23: 2.01 Q3 '23: 1.55 Q4 '23: 1.15 Q1 '24: 0.62 Q2 '24: 0.28 Q3 '24: 0.65 Q4 '24: 0.75 Q1 '25: 1.34 Q2 '25: 2.60 Q3 '25: 3.10 Q4 '25: 3.93 Q1 '26: 4.29 Q2 '26: 3.90 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.